Extracellular vesicles as a drug delivery system: A systematic review of preclinical studies

Publication date

2021-08

Authors

Martinez de Castilla, Pol Escudé
Tong, Lingjun
Huang, Chenyuan
Sofias, Alexandros Marios
Pastorin, Giorgia
Chen, Xiaoyuan
Storm, Gert
Schiffelers, RaymondORCID 0000-0002-1012-9815ISNI 0000000045237985
Wang, Jiong-Wei

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

taverne

Abstract

During the past decades, extracellular vesicles (EVs) have emerged as an attractive drug delivery system. Here, we assess their pre-clinical applications, in the form of a systematic review. For each study published in the past decade, disease models, animal species, EV donor cell types, active pharmaceutical ingredients (APIs), EV surface modifications, API loading methods, EV size and charge, estimation of EV purity, presence of biodistribution studies and administration routes were quantitatively analyzed in a defined and reproducible way. We have interpreted the trends we observe over the past decade, to define the niches where to apply EVs for drug delivery in the future and to provide a basis for regulatory guidelines.

Keywords

Clinical trial, Drug delivery, Extracellular vesicles, Liposomes, Preclinical animal models, Systematic review, Taverne, Pharmaceutical Science, Review, Journal Article

Citation

Escudé Martinez de Castilla, P, Tong, L, Huang, C, Sofias, A M, Pastorin, G, Chen, X, Storm, G, Schiffelers, R M & Wang, J-W 2021, 'Extracellular vesicles as a drug delivery system : A systematic review of preclinical studies', Advanced Drug Delivery Reviews, vol. 175, 113801, pp. 1-39. https://doi.org/10.1016/j.addr.2021.05.011